ReviewJournal of immunology (Baltimore, Md. : 1950)2022

Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of Alloimmunity.

Kavitha Muralidharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.